Advanced 3D medical imaging software
Revolutionizing oncology trials through expert central reads with improved standardization, reproducibility, quantitative organ health metrics, and tumour burden metrics. Allowing sponsors to characterize disease burden better and monitor tumor progression and response to treatment.
Recist
mRecist
Percist
Volume
Location
Activity
Enhanced screening and monitoring with cT1
cT1 better identifies patients for enrolment, more accurately detects early efficacy signals and pseudo-progression, and quantitatively monitors drug-induced liver injury.
Custom imaging protocols and central read workflows
Our customizable imaging protocols allow for non-invasive quantification of organ health to be safely captured, delivering comprehensive solutions to meet the needs of your clinical trial.
MRI
CT
PET
DXA
Endosocopy
Digital Pathology